Dr Lal PathLabs AGM to approve ₹4 dividend on July 25

1 min read     Updated on 03 Jul 2026, 04:43 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Dr Lal PathLabs Limited has announced its 32nd Annual General Meeting for July 25, 2026, to be held via video conferencing. The primary agenda includes the approval of a final dividend of ₹4 per equity share for the financial year ended March 31, 2026, with a record date set for June 26, 2026. Shareholders will also vote on the re-appointment of (Hony) Brig Dr Arvind Lal as Executive Chairman and Mr. Rajit Mehta as Non-Executive Independent Director, along with special resolutions to revise remuneration for senior leadership and ratify auditor fees.

powered bylight_fuzz_icon
44310944

*this image is generated using AI for illustrative purposes only.

Dr. Lal PathLabs Limited has scheduled its 32nd Annual General Meeting for Saturday, July 25, 2026, at 10:00 A.M. IST via Video Conferencing. Shareholders will vote on a final dividend of ₹4 per equity share for the financial year ended March 31, 2026, and consider the re-appointment of key directors including (Hony) Brig Dr Arvind Lal as Executive Chairman. The record date for dividend eligibility is June 26, 2026, with payment expected on or before August 23, 2026.

The meeting will be conducted through Video Conferencing or Other Audio Visual Means (VC/OAVM), allowing remote participation. The agenda includes adopting the audited standalone and consolidated financial statements for FY26. Shareholders will also vote on special resolutions to revise the remuneration structures for (Hony) Brig Dr Arvind Lal and Dr Vandana Lal, effective from April 1, 2026.

Key Resolutions

The Board has proposed the re-appointment of (Hony) Brig Dr Arvind Lal as Executive Chairman and Whole-Time Director for a five-year term commencing April 1, 2027. Additionally, Mr. Rajit Mehta is proposed for re-appointment as a Non-Executive Independent Director for a second term of five years from July 27, 2026, to July 26, 2031.

Remuneration and Appointments

The company seeks shareholder approval to revise the remuneration for its senior leadership. The proposed monthly remuneration ranges are detailed below:

Director Tenure Monthly Remuneration Range (₹ Lakh)
(Hony) Brig Dr Arvind Lal April 1, 2026 – March 31, 2027 33.00 – 37.50
(Hony) Brig Dr Arvind Lal April 1, 2027 – March 31, 2032 37.50 – 60.00
Dr Vandana Lal April 1, 2026 – March 31, 2030 30.00 – 50.00

Further resolutions include ratifying the remuneration of Cost Auditors M/s. A.G. Agarwal & Associates at ₹2,00,000 plus applicable taxes for FY27. The Board also seeks approval to pay commission to Non-Executive Directors, capped at ₹1.25 crore for the Lead Independent Director and ₹75 lakh for other directors annually for three years starting April 1, 2026.

Historical Stock Returns for Dr. Lal Path Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+4.27%+1.53%+5.37%+27.81%+16.61%+2.22%

What strategic growth initiatives justify the significant proposed increase in remuneration for the senior leadership starting in 2027?

How will the re-appointment of (Hony) Brig Dr Arvind Lal for a five-year term influence the company's long-term succession planning strategy?

What impact will the increased commission caps for Non-Executive Directors have on shareholder sentiment and corporate governance standards?

Dr Lal PathLabs files BRSR for FY 2025-26

1 min read     Updated on 02 Jul 2026, 05:18 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Dr Lal PathLabs filed its Business Responsibility and Sustainability Report for FY 2025-26, reporting total energy consumption of 79,829 GJ and CSR expenditure of ₹10.54 million. The report details environmental metrics, workforce data, and governance compliance.

powered bylight_fuzz_icon
44439239

*this image is generated using AI for illustrative purposes only.

Dr Lal PathLabs filed its Business Responsibility and Sustainability Report for the financial year 2025-26 with the National Stock Exchange of India and BSE Limited. The disclosure, submitted by Vinay Gujral, Company Secretary & Compliance Officer, outlines the company's performance against the National Guidelines on Responsible Business Conduct (NGRBC).

The report details environmental metrics such as total energy consumption of 79,829 GJ and water withdrawal of 1,36,426 kilolitres, alongside social data including a workforce of 5,611 and CSR expenditure of ₹10.54 million.

Environmental Performance

The company reported a total energy consumption of 79,829 GJ for FY 2025-26, comprising 12,000 GJ from renewable sources and 67,829 GJ from non-renewable sources. The energy intensity stood at 0.0000000012 GJ per rupee of revenue from operations.

Water withdrawal totalled 1,36,426 kilolitres, entirely sourced from municipal corporations, with total water discharge matching the withdrawal volume. The water intensity was reported at 0.00000000014 kilolitres per rupee of revenue from operations.

Regarding waste management, the entity generated 829.44 metric tonnes of total waste. This included 8.08 metric tonnes of non-hazardous waste and 821.36 metric tonnes of other waste. The company recovered 1.61 metric tonnes through recycling and re-using operations, while 827.84 metric tonnes were disposed of via incineration and other methods.

Social and Governance Metrics

As of March 31, 2026, the company employed 1,981 individuals and engaged 3,630 workers. The workforce included 29 differently abled workers and 2 differently abled employees. The report noted that 98.69% of employees and 99.12% of workers received training on human rights issues.

The company reported no instances of fines, penalties, or imprisonment related to regulatory non-compliance during the year. It also recorded zero data breaches and no product recalls due to safety issues.

Corporate Social Responsibility

Corporate Social Responsibility (CSR) activities were applicable for the year. The company spent a total of ₹10.54 million on CSR projects undertaken in designated aspirational districts. The report indicated that the company does not have a preferential procurement policy for marginalized or vulnerable groups.

The filing confirms that the Board has approved policies covering all nine principles of the NGRBC. An independent assurance statement was provided by J Sundharesan & Associates, verifying the BRSR core indicators.

Historical Stock Returns for Dr. Lal Path Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+4.27%+1.53%+5.37%+27.81%+16.61%+2.22%

How does Dr Lal PathLabs plan to increase its renewable energy consumption from the current 15% to meet future sustainability targets?

What specific strategies will the company implement to improve its low waste recovery rate of less than 0.2%?

Will the introduction of a preferential procurement policy for marginalized groups be considered in upcoming fiscal years?

More News on Dr. Lal Path Labs

Must Read Next

Earnings

REC Reports Decline in Q1 Net Profit and Revenue on Year-on-Year Basis 1 min ago
no imag found
Ratnaveer Precision Engineering Reports Q1 Revenue of 3.15B Rupees, Net Profit Rises to 182M Rupees YoY 28 mins ago
Bank of Baroda Q1 Results: Net Profit Slumps to 12.78B Rupees, Misses Estimates; Asset Quality Weakens 28 mins ago

Stocks

Torm Innovation Reroutes Via Suez Canal, Bypasses Southern Red Sea Amid Safety Concerns 15 mins ago
no imag found
Indo Tech Transformers Receives NTPC Approval to Manufacture 400 KV Class Transformers for BESS Projects 19 mins ago
1 Year Returns:+16.61%